Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedVersion bump from v3.6.4 to v3.6.5 on the page, signaling an update to the site's software. This change does not modify the study content or its data presented on the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a revision tag update from v3.6.3 to v3.6.4, indicating a new site version rather than a modification to the study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page shows a revision update from v3.6.2 to v3.6.3, indicating a minor update to the page version. This reflects a small change to the page’s metadata or formatting without altering the study details.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new version of the page. This update does not modify the study details or visible content.SummaryDifference0.1%

- Check58 days agoChange DetectedEnrollment status updated to No longer looking for participants, affecting recruitment visibility. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with an updated Intervention/Treatment heading and the Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.4%

- Check65 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5, reflecting a software version update on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.